Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1993 1
1994 4
1997 3
1998 1
1999 1
2002 2
2003 1
2007 3
2008 1
2009 2
2010 2
2011 1
2012 2
2013 3
2014 1
2015 6
2016 5
2017 1
2018 4
2019 3
2020 2
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy.
Haikala HM, Anttila JM, Marques E, Raatikainen T, Ilander M, Hakanen H, Ala-Hongisto H, Savelius M, Balboa D, Von Eyss B, Eskelinen V, Munne P, Nieminen AI, Otonkoski T, Schüler J, Laajala TD, Aittokallio T, Sihto H, Mattson J, Heikkilä P, Leidenius M, Joensuu H, Mustjoki S, Kovanen P, Eilers M, Leverson JD, Klefström J. Haikala HM, et al. Among authors: klefstrom j. Nat Commun. 2019 Feb 6;10(1):620. doi: 10.1038/s41467-019-08541-2. Nat Commun. 2019. PMID: 30728358 Free PMC article.
UBR5 Is Coamplified with MYC in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis.
Qiao X, Liu Y, Prada ML, Mohan AK, Gupta A, Jaiswal A, Sharma M, Merisaari J, Haikala HM, Talvinen K, Yetukuri L, Pylvänäinen JW, Klefström J, Kronqvist P, Meinander A, Aittokallio T, Hietakangas V, Eilers M, Westermarck J. Qiao X, et al. Among authors: klefstrom j. Cancer Res. 2020 Apr 1;80(7):1414-1427. doi: 10.1158/0008-5472.CAN-19-1647. Epub 2020 Feb 6. Cancer Res. 2020. PMID: 32029551 Free article.
MYC and AMPK-Save Energy or Die!
Haikala HM, Anttila JM, Klefström J. Haikala HM, et al. Among authors: klefstrom j. Front Cell Dev Biol. 2017 Apr 11;5:38. doi: 10.3389/fcell.2017.00038. eCollection 2017. Front Cell Dev Biol. 2017. PMID: 28443281 Free PMC article. Review.
Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy.
Haikala HM, Anttila JM, Marques E, Raatikainen T, Ilander M, Hakanen H, Ala-Hongisto H, Savelius M, Balboa D, Von Eyss B, Eskelinen V, Munne P, Nieminen AI, Otonkoski T, Schüler J, Laajala TD, Aittokallio T, Sihto H, Mattson J, Heikkilä P, Leidenius M, Joensuu H, Mustjoki S, Kovanen P, Eilers M, Leverson JD, Klefström J. Haikala HM, et al. Among authors: klefstrom j. Nat Commun. 2019 Feb 20;10(1):932. doi: 10.1038/s41467-019-08956-x. Nat Commun. 2019. PMID: 30787321 Free PMC article.
Faulty epithelial polarity genes and cancer.
Tervonen TA, Partanen JI, Saarikoski ST, Myllynen M, Marques E, Paasonen K, Moilanen A, Wohlfahrt G, Kovanen PE, Klefstrom J. Tervonen TA, et al. Among authors: klefstrom j. Adv Cancer Res. 2011;111:97-161. doi: 10.1016/B978-0-12-385524-4.00003-9. Adv Cancer Res. 2011. PMID: 21704831 Review.
Par6 family proteins in cancer.
Marques E, Klefström J. Marques E, et al. Among authors: klefstrom j. Oncoscience. 2015 Oct 7;2(11):894-5. doi: 10.18632/oncoscience.255. eCollection 2015. Oncoscience. 2015. PMID: 26697513 Free PMC article. No abstract available.
Myc protein: partners and antagonists.
Västrik I, Mäkelä TP, Koskinen PJ, Klefstrom J, Alitalo K. Västrik I, et al. Among authors: klefstrom j. Crit Rev Oncog. 1994;5(1):59-68. doi: 10.1615/critrevoncog.v5.i1.30. Crit Rev Oncog. 1994. PMID: 7948108 Review.
50 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page